Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000134

Chief Scientific Officer acquired 13,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kishimoto Takashi Kei Chief Scientific Officer 2021-10-01 Grant or award +13,750 194,281 D: show line 1 in the form
Loading xslF345X03/wf-form4_163346556411169.xml…